top
Search terms
Results 1 - 7 of 7 - ordered by :
Escardio

Whereas most clinical trials have focused only on reducing mortality, the latest analyses of the SHIFT trial have shown the importance of a reduction in recurrent hospitalizations and quality of life ...

SHIFTing evidence in heart failure management

Date : 26/05/2013 Item size : 86532 bytes
Escardio

Session Details Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes 31 Aug 14:45 - 16:15 Antithrombotic agents EBAC Accredited ...

Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes

Date : 31/08/2013 Item size : 75305 bytes
Escardio

Chairpersons: Gilles MONTALESCOT (Paris, FR) Subtitle: Sponsored by Daiichi Sankyo Europe GmbH Learning Objectives: To understand the impact of length of treatment with dual antiplatelet drugs in ...

Dual antiplatelet treatment duration in Acute Coronary Syndrome (ACS) - Percutaneous Coronary Intervention (PCI): one for all or all for one?

Date : 30/08/2015 Item size : 62632 bytes
Escardio

Session Details Evidence and evolution in Pulmonary Arterial Hypertension (PAH) 31 Aug 12:45 - 13:45 Chronic pulmonary hypertension Satellite Symposium San Marino - Village 2 Chairpersons: Marius M ...

Evidence and evolution in Pulmonary Arterial Hypertension (PAH)

Date : 31/08/2015 Item size : 69553 bytes
Escardio

Understand the unmet need for additional LDL-C-lowering therapies beyond current optimal statin-based therapy as a strategy for addressing lipid-related CV risk in patients with FH Understand the ...

PCSK9 inhibition in lipid management: final steps towards implementation into clinical practice

Date : 29/08/2015 Item size : 67193 bytes
Escardio

[...]the importance of tailoring treatment duration to the patient will be highlighted.

Dual anti-platelet therapy in atherothrombosis in 2015: debating the evidence

Date : 01/09/2015 Item size : 62863 bytes
Escardio

Session Details Diabetes & heart failure: evaluating novel strategies to address outcomes 21 May 12:45 - 13:45 Chronic heart failure EBAC Accredited Educational Programme Athens - ...

Diabetes & heart failure: evaluating novel strategies to address outcomes

Date : 21/05/2016 Item size : 81222 bytes